A detailed history of Intech Investment Management LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 61,828 shares of PCVX stock, worth $4.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
61,828
Previous 28,228 119.03%
Holding current value
$4.6 Million
Previous $3.22 Million 57.08%
% of portfolio
0.05%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$80.97 - $117.93 $2.72 Million - $3.96 Million
33,600 Added 119.03%
61,828 $5.06 Million
Q3 2024

Nov 08, 2024

BUY
$70.52 - $117.12 $1.99 Million - $3.31 Million
28,228 New
28,228 $3.22 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $4.41B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.